| Size & multiples | |||
| Market Cap | $69.2M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | — | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −61.21% | Buyback Yield | — |
| Owner Earnings (TTM) | -$38.8M | Owner Earnings Yield | −56.03% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.84 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 8.18% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$1.49 · revenue TTM $0 · FCF TTM -$42.4M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -58.1% | -7.8% | -34.7%–1.4% | 18 ↓weak |
| Dividend Yield | 0.0% | 1.1% | 0.2%–2.4% | 10 ↓weak |
| ROE | -28.2% | -36.8% | -92.5%–4.5% | 55 ↑strong |
